Skip to content

13F-HR filed by GEODE CAPITAL MANAGEMENT, LLC

GEODE CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-13, with 4,031 holding rows worth $294,473,523,000.

Accession
0001214717-18-000002
Filed
2018-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 4,803 entries on the cover page, a total value of $294,473,523,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $294,473,523,000 with VALUE read as thousands by filing date, 13F file number 028-10386. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
O2MICRO INTERNATIONAL LTD67107W100SPONS ADR13,662$22,000thousands by filing date
ORAGENICS INC684023302COM PAR89,941$21,000thousands by filing date
AVINGER INC053734208COM NEW115,517$21,000thousands by filing date
Gevo Inc stock374396307Stock35,762$21,000thousands by filing date
COMSTOCK MNG INC205750201COM NEW56,140$21,000thousands by filing date
AMERICAN ELECTRIC TECHNOLOGIES025576109COMM11,601$17,000thousands by filing date
ADDVANTAGE TECHNOLOGIES GRP006743306CMN11,928$17,000thousands by filing date
ARGOS THERAPEUTICS ORD040221202COM114,999$17,000thousands by filing date
LIGHTBRIDGE CORP53224K203COM NEW13,315$16,000thousands by filing date
CHINA COML CR INC16891K103COM11,141$15,000thousands by filing date
RXI PHARMACEUTICALS CORP NEW74979C808COM PAR26,638$14,000thousands by filing date
ONCOBIOLOGICS INC68235M105COM11,165$14,000thousands by filing date
AFFIMED N VN01045108COM10,000$13,000thousands by filing date
MICRONET ENERTEC TECH595117102COMMON11,589$12,000thousands by filing date
IMMUNE PHARMACEUTICALS INC45254C200COM NEW22,355$12,000thousands by filing date
INTELLIPHARMACEUTICS INTERNA458173101CMN13,756$11,000thousands by filing date
ORIGIN AGRITECH LIMITEDG67828106SHS10,619$9,000thousands by filing date
RITTER PHARMACEUTICALS INC767836109COM29,614$9,000thousands by filing date
PENGROWTH ENERGY CORP70706P104COMMON STOCK-FO11,159$8,000thousands by filing date
JRJR33 INCORPORATED46645Q106Common Stock44,389$8,000thousands by filing date
ARCADIA BIOSCIENCES INC COM039014204Stock26,228$7,000thousands by filing date
ARCADIA BIOSCIENCES INC039014105COM26,228$7,000thousands by filing date
OPGEN INC68373L208COM NEW41,093$7,000thousands by filing date
AURIS MED HLDG AGH03579101COM12,197$7,000thousands by filing date
RAND LOGISTICS INC752182105COM43,254$6,000thousands by filing date
NEOVASC INC COM STK64065J106COM11,628$6,000thousands by filing date
Regional Health Properties Inc75903M101COM40,556$6,000thousands by filing date
MAGNEGAS CORP55939L400COM PAR14,443$4,000thousands by filing date
IMMUNOCELLULAR THERAPEUTICS452536204COM NEW10,995$3,000thousands by filing date
JAGUAR HEALTH INC47010C201COM27,742$3,000thousands by filing date
AKERS BIOSCIENCES INC00973E102COM12,000$1,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214717-18-000002this filing2018-02-13acceptance time not in the bulk data set